Analysis of Antihypertensive Treatment Efficacy (ATACA)

AstraZeneca

Status: Terminated

Conditions: Arterial Hypertension

Study type: Observational

Funder types: Industry

Identifiers

NCT00767247

NIS-CRU-ATA-2008/1

Details and patient eligibility

About

Analysis of antihypertensive treatment efficacy.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• arterial hypertension
• intake of Atacand before study enrollment

Exclusion criteria

• hypersensitivity to candesartan or any other ingredient of Atacand
• liver function impairment and/or cholestasis
• severe renal insufficiency (serum creatinine > 265 µmol/L)
• Pregnant and lactating women

Trial design

2,000 participants in 1 patient group

1

Description:

Male or female with arterial hypertension